Skip to Main Content

Author Details

Masoom A Haider
University Health Network
1995
266
61
PMIDPaper TitleJournal TitlePublished Year
37973244Contemporary Approach to Prostate Imaging and Data Reporting System Score 3 Lesions.Radiol Clin North Am2024
37620233Re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging After Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629-634.Eur Urol Oncol2024
37838556Magnetic Resonance Imaging-Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE).Eur Urol Oncol2024
36710133Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting.Eur Urol Oncol2023
37720416Development of a Radiomics-Based Model to Predict Graft Fibrosis in Liver Transplant Recipients: A Pilot Study.Transpl Int2023
37717419Inter-reader variability and reproducibility of the PI-QUAL score in a multicentre setting.Eur J Radiol2023
35778618T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.Skeletal Radiol2023
37160473mpMRI Interpretation in Active Surveillance for Prostate Cancer-An overview of the PRECISE score.Abdom Radiol (NY)2023
37074425Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions.Eur Radiol2023
37365116Hepatocellular adenoma subtyping by qualitative MRI features and machine learning algorithm of integrated qualitative and quantitative features: a proof-of-concept study.Clin Radiol2023
36809425The role of [<sup>18</sup>F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer.Eur J Nucl Med Mol Imaging2023
34324385Role of multiparametric MRI in long-term surveillance following focal laser ablation of prostate cancer.Br J Radiol2022
35507051Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy.Eur Radiol2022
35766531Radiomics in Abdominopelvic Solid-Organ Oncologic Imaging: Current Status.AJR Am J Roentgenol2022
35536139It's Time for a Standardized MRI Assessment Scheme for Prostate Cancer Recurrence.Radiology2022
35534628Exploring the value of using patient-oriented MRI reports in clinical practice - a pilot study.Support Care Cancer2022
35852425Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.Radiology2022
35718075A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients.Pract Radiat Oncol2022
35622151Correction to: Exploring the value of using patientâ¿¿oriented MRI reports in clinical practice - a pilot study.Support Care Cancer2022
36551709CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling.Cancers (Basel)2022
35971326Canadian Association of Radiologists Prostate MRI White Paper.Can Assoc Radiol J2022
36351725Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial.BMJ Open2022
36006427Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma.Eur Radiol2022
34860562Deep learning-based artificial intelligence applications in prostate MRI: brief summary.Br J Radiol2022
34877870Artificial Intelligence for Automated Cancer Detection on Prostate MRI: Opportunities and Ongoing Challenges, From the <i>AJR</i> Special Series on AI Applications.AJR Am J Roentgenol2022
35113918A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancer.PLoS One2022
35024633Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium.Eur Urol Open Sci2022
35232991Synthetic correlated diffusion imaging hyperintensity delineates clinically significant prostate cancer.Sci Rep2022
35133265Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer: A Cancer Care Ontario updated clinical practice guideline.Can Urol Assoc J2022
35103829Balancing the benefits and harms of MRI-directed biopsy pathways.Eur Radiol2022
34757450Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.Eur Radiol2022
34633212Editorial Comment.J Urol2022
32749585Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?Eur Radiol2021
33908267Beyond the <i>AJR</i>: "Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography: The IP1-PROSTAGRAM Study".AJR Am J Roentgenol2021
33900880MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.Radiology2021
33538782Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial.JAMA Oncol2021
33582104Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy.Eur Urol Oncol2021
33529137MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.Radiology2021
34526699Federated learning for predicting clinical outcomes in patients with COVID-19.Nat Med2021
34400038Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: an Updated Systematic Review.Clin Oncol (R Coll Radiol)2021
33991226ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imaging.Eur Radiol2021
33934171Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer.Eur Radiol2021
33982917A Pre-TACE Radiomics Model to Predict HCC Progression and Recurrence in Liver Transplantation: A Pilot Study on a Novel Biomarker.Transplantation2021
34032510Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.Radiology2021
34362709Standardized Reporting of Machine Learning Applications in Urology: The STREAM-URO Framework.Eur Urol Focus2021
33977352Prostate minimally invasive procedures: complications and normal vs. abnormal findings on multiparametric magnetic resonance imaging (mpMRI).Abdom Radiol (NY)2021
34254200A Comprehensive Study of Data Augmentation Strategies for Prostate Cancer Detection in Diffusion-Weighted MRI Using Convolutional Neural Networks.J Digit Imaging2021
33446870Improving prognostic performance in resectable pancreatic ductal adenocarcinoma using radiomics and deep learning features fusion in CT images.Sci Rep2021
33355501Reply by Authors.J Urol2021
33442676Federated Learning used for predicting outcomes in SARS-COV-2 patients.Res Sq2021
  • 1 - 50 of 266

Recommended Authors

Anthony Sisk
University of California los angeles
Career Start Year 2017
Number of shared co-authors 5
Amirhossein Mohammadian Bajgiran
David Geffen School of Medicine at university of california los angeles
Career Start Year 2016
Number of shared co-authors 1
Jeremie Calais
university of california los angeles
Career Start Year 2014
Number of shared co-authors 5
Nazanin H Asvadi
Saint Vincent Hospital
Career Start Year 2013
Number of shared co-authors 1
Neil Mendhiratta
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 4
Stephanie A Lee-Felker
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 2012
Number of shared co-authors 1
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 9
Sohrab Afshari Mirak
University Hospitals Cleveland Medical Center/Case Western Reserve University
Career Start Year 2011
Number of shared co-authors 1
Raquel Perez-Lopez
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2010
Number of shared co-authors 1
Kyunghyun Sung
University of California los angeles
Career Start Year 2008
Number of shared co-authors 1
Spencer C Behr
University of California san francisco
Career Start Year 2007
Number of shared co-authors 3
Thomas A Hope
University of California san francisco
Career Start Year 2007
Number of shared co-authors 5
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 9
Nelly Tan
Department of Radiology at the Mayo Clinic Hospital in Phoenix
Career Start Year 2007
Number of shared co-authors 1
Nina Tunariu
The Institute of Cancer Research
Career Start Year 2005
Number of shared co-authors 4
Huihui Ye
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 6
Iva Petkovska
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 19
Kyle R Padgett
Sylvester Comprehensive Cancer Center, Miller School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 3
Timothy D McClure
Weill Cornell Medical College/New York Presbyterian
Career Start Year 2002
Number of shared co-authors 1
Chaya S Moskowitz
Memorial Sloan Kettering Cancer Center.
Career Start Year 2002
Number of shared co-authors 0
Steven S Raman
University of California, Los Angeles David Geffen School of Medicine
Career Start Year 1999
Number of shared co-authors 7
Amita Shukla-Dave
Memorial Sloan Kettering Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Richard K G Do
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 5
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Career Start Year 1993
Number of shared co-authors 11
Elizabeth C Jones
Clinical Center, National Institutes of Health
Career Start Year 1989
Number of shared co-authors 9
Stuart G Silverman
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1988
Number of shared co-authors 1
Marcelino Bernardo
Center for Interventional Oncology, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 3
Ely R Felker
University of California, Los Angeles David Geffen School of Medicine
Career Start Year 1973
Number of shared co-authors 4

Collaborators

Farzad Khalvati
Research Institute, The Hospital for Sick Children
Co-authored papers 30
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 28
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers 27
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 23
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 23
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Co-authored papers 19
Neil E Fleshner
University of Toronto
Co-authored papers 16
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 16
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers 15
Baris Turkbey
National Cancer Institute, National Institutes of Health
Co-authored papers 12
Daniel J Margolis
Weill Cornell Medical College
Co-authored papers 11
Joseph L Chin
University of Western Ontario
Co-authored papers 10
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 10
Ants Toi
Mount Sinai Hospital, University of Toronto
Co-authored papers 9
Anthony Fyles
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 9
Peter L Choyke
National Cancer Institute, National Institutes of Health
Co-authored papers 7
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Co-authored papers 7
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Co-authored papers 5
Martin E Gleave
University of British Columbia
Co-authored papers 4
Katherine Lajkosz
Princess Margaret Hospital
Co-authored papers 4
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 4
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 4
Robert G Bristow
University of Toronto
Co-authored papers 4
Madeleine Moussa
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 3
David Robert Siemens
Queen's University
Co-authored papers 3
Gail Darling
University of Toronto
Co-authored papers 3
Jure Murgic
University Hospital Center Sestre Milosrdnice
Co-authored papers 3
Michelle R Downes
University of Toronto
Co-authored papers 2
Xihong Lin
Harvard T.H. Chan School of Public Health
Co-authored papers 2
Tony Mazzulli
Mount Sinai Health System and University Health Network
Co-authored papers 2
Release 1.2